Yatharth Hospital & Trauma Care Services Ltd (YATHARTH) — shareholding pattern, promoter holding, financials and share price
About Yatharth Hospital & Trauma Care Services Ltd (YATHARTH)
Yatharth Hospital & Trauma Care Services Ltd operates in the Hospital industry, within the Healthcare sector. It trades on the NSE as YATHARTH and on the BSE under scrip code 543950. Its ISIN is INE0JO301016.
Incorporated in 2008, Yatharth Hospital and Trauma Care Services Limited is a multi-care hospitals at Noida, Greater Noida, and Noida Extension, Uttar Pradesh. [1]
Yatharth Hospital & Trauma Care Services Limited operates a network of super‑speciality tertiary and quaternary hospitals concentrated in the Delhi NCR and select North Indian markets, delivering complex specialties such as oncology, cardiology, neurosciences, robotic surgeries and organ transplants across eight hospitals and a reported bed capacity above 2,550 as of Q3 FY26.
Q3 FY26 was the company’s strongest quarter with revenue of Rs.3,205 million (+46% YoY) and EBITDA of Rs.742 million; management reports an adjusted EBITDA margin of 29.2% excluding ramp‑up losses from New Delhi and Faridabad Sec‑20, indicating meaningful operating leverage from ARPOB gains and higher super‑speciality mix.
Listed peers in Hospital: Park Medi World Ltd, Healthcare Global Enterprises Ltd, Jupiter Life Line Hospitals Ltd, Kovai Medical Center & Hospital Ltd, Artemis Medicare Services Ltd, Indraprastha Medical Corporation Ltd.
Valuation & Returns
10 Jul 2026At ₹829.05 a share on 10 Jul 2026, Yatharth Hospital & Trauma Care Services Ltd (YATHARTH) was valued at a price-to-earnings ratio of 46.7x against an industry P/E of 61.73x and a price-to-book of 4.98x on a book value of ₹166.62 per share as of Mar 2025. Solomo computes return on equity of 10.66% and return on capital employed of 14.17% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 46.7x
- Industry P/E
- 61.73x
- P/B
- 4.98x
- EPS (TTM)
- ₹17.75
- Book value / share
- ₹166.62
- ROE
- 10.66%
- ROCE
- 14.17%
- ROA
- 9.88%
- Debt / equity
- 0.01x
- Dividend yield
- 0%
- EBITDA margin
- 26.43%
- 52-week range
- ₹538.15 – ₹889.8
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Yatharth Hospital & Trauma Care Services Ltd (YATHARTH) reported revenue of ₹1,207 crore, net profit of ₹170 crore and earnings per share of ₹18.2. That compares with revenue of ₹860 crore and net profit of ₹131 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹342 crore and net profit ₹45 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 375 | 478 | 635 | 860 | 1,207 |
| Net profit (₹ cr) | 44 | 66 | 114 | 131 | 170 |
| EPS (₹) | 6.74 | 10.04 | 13.33 | 13.55 | 18.2 |
| Measure | 5Y | 3Y | 1Y |
|---|---|---|---|
| Sales growth | 27.90% | 15.01% | 31.31% |
| Profit growth | 156.10% | 27.72% | 14.04% |
| Stock price CAGR | - | - | 42% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 55.8% of Yatharth Hospital & Trauma Care Services Ltd (YATHARTH) (unchanged from the previous quarter), foreign institutional investors (FII) hold 5.62% and domestic institutional investors (DII) hold 10.84%. Promoters have pledged 9.6% of their holding. Market capitalisation was ₹7,988 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2023.
Largest disclosed public shareholders in Jun 2026: Kotak Mahindra Trustee Co Ltd A/C Kotak Multicap Fund 5%, Bandhan Small Cap Fund 4.24%, Jupiter India Fund 1.16%, Mukul Mahavir Agrawal 1.14%, Kedia Securities Private Limited 1%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 55.8% | 9.6% | 5.62% | 10.84% | 44.2% |
| Mar 2026 | 55.8% | 10.7% | 5.25% | 12% | 44.2% |
| Dec 2025 | 55.8% | 10.7% | 6.18% | 11.01% | 44.2% |
| Sep 2025 | 61.64% | 15.3% | 6.5% | 8.7% | 38.36% |
| Jun 2025 | 61.64% | 13.8% | 4.34% | 13.52% | 38.36% |
| Mar 2025 | 61.64% | 13.8% | 4.45% | 13.56% | 38.36% |
| Dec 2024 | 61.44% | - | 9.78% | 11.5% | 38.56% |
| Sep 2024 | 66.54% | - | 6.28% | 6.98% | 33.46% |